Biochemistry and Biology of Complement Activation

  • W. Opferkuch
  • M. Segerling
Part of the Comprehensive Immunology book series (COMIMUN, volume 2)


The immunological response of the organism to a foreign antigen involves both the humoral and cellular immune system. When antigen is recognized by humoral antibodies, this recognition step is the trigger of a biological reaction mediated by the complement system. The complement system, therefore, may be considered as the effector and amplification system of the humoral immune reaction.


Polypeptide Chain Complement Activation Complement System Hemolytic Activity Complement Component 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Almeida, J. D., Waterson, A. P., 1969, The morphology of virus-antibody interaction, Adv. Virus Res. 15: 307.PubMedGoogle Scholar
  2. Arroyave, C. M., Müller-Eberhard, H. J., 1973, Interactions between human C5, C6 and C7 and their functional significance in complement-dependent cytolysis, J. Immunol. 111: 536.PubMedGoogle Scholar
  3. Assimeh, S., Painter, R. H., 1975, The identification of a previously unrecognized subcomponent of the first component of complement, J. Immunol. 115: 482–487.PubMedGoogle Scholar
  4. Augener, W., Grey, H. N., Cooper, N. R., Müller-Eberhard, H. J., 1971, The reaction of monomeric and aggregated immunoglobulins with CI, Immunochemistry 8: 1111.Google Scholar
  5. Austen, K. F., ed., 1974, The immunobiology of complement, Transpl. Proc. 6:1.Google Scholar
  6. Becker, E. L., 1956, Concerning the mechanism of complement action. II. The nature of the first component of guinea pig complement, J. Immunol. 77: 469.PubMedGoogle Scholar
  7. Bokisch, V. A., Müller-Eberhard, H. J., 1970, Anaphylatoxin inactivator of human plasma: its isolation and characterization as a carboxypeptidase, J. Clin. Invest. 49: 2427.PubMedGoogle Scholar
  8. Bokisch, V. A., Cochrane, C. G., Müller-Eberhard, H. J., 1969, Isolation of a fragment (C3a) of the third component of human complement containing anaphylatoxin and chemotactic activity and description of an anaphylatoxin inactivator of human serum, J. Exp. Med. 129: 1109.PubMedGoogle Scholar
  9. Borsos, T., Opferkuch, W., 1970, Kinetics and assay of complement components; clustering and hemolytic competence of 42-complexes at a single site, in: Biologic Activities of Complement, Fifth International Symposium of the Canadian Society for Immunology, Guelph 1970 ( D. G. Ingram, ed.), pp. 27–38, Karger, Basel.Google Scholar
  10. Borsos, T., Rapp, H. J., 1965, Complement fixation on cell surfaces by 19S and 7S antibodies, J. Science 150: 505.Google Scholar
  11. Borsos, T., Rapp, H. J., Mayer, M. M., 1961a, Studies on the second component of complement. I. The reaction between EAC14 and C2: evidence on the single site mechanism of immune hemolysis and determination of C2 on a molecular basis, J. Immunol. 87: 310.Google Scholar
  12. Borsos, T., Rapp, H. J., Mayer, M. M., 1961b, Studies on the second component of complement. II. The nature of the decay of EAC 1, 4, 22, J. Immunol. 87: 326–329.Google Scholar
  13. Borsos, T., Dormashkin, R. R., Humphrey, J. H., 1964, Lesions in erythrocyte membranes caused by immune haemolysis, Nature 4929: 251.Google Scholar
  14. de Bracco, M. M. E., Stroud, R. M., 1971, Clr, subunit of the first complement component: purification, properties and assay based on its linking role, J. Clin. Invest. 50: 838.PubMedGoogle Scholar
  15. Budzko, D. B., Müller-Eberhard, H. J., 1970, Cleavage of the fourth component of human complement (C4) by CI esterase: isolation and characterization of the low molecular weight product, Immunochemistry 7: 228.Google Scholar
  16. Calcott, M. A., Müller-Eberhard, H. J., 1972, Clq protein of human complement, Biochemistry 11: 3443.PubMedGoogle Scholar
  17. Cochrane, C. G., Müller-Eberhard, H. J., 1968, The derivation of two distinct anaphylatoxin activities from the third and fifth component of human complement J. Exp. Med. 127: 371.PubMedGoogle Scholar
  18. Colten, H. R., Borsos, T., Rapp, H. J., 1968, Ultracentrifugation of the first component of complement: effects of ionic strength, J. Immunol. 1)): 808.Google Scholar
  19. Conradie, J. D., Volanakis, J. E., Stroud, R. M., 1975, Evidence for a serum inhibitor of Clq, Immunochemistry 12: 967–971.PubMedGoogle Scholar
  20. Cooper, N. R., 1969, Immune adherence by the fourth component of complement, Nature 165: 396.Google Scholar
  21. Cooper, N. R., 1975, Isolation and analysis of the mechanism of action of an inactivator of C4b in normal human serum, J. Exp. Med. 141: 890.PubMedGoogle Scholar
  22. Cooper, N. R., Müller-Eberhard, H. J., 1968, A comparison of methods for the molecular quantitation of the fourth component of human complement, Immunochemistry 5: 155.PubMedGoogle Scholar
  23. Cooper, N. R., Müller-Eberhard, H. J., 1971, The reaction mechanism of human C5 in immune hemolysis, J. Exp. Med. 132: 775.Google Scholar
  24. Daniels, C. A., Borsos, T., Rapp, H. J., Snyderman, R., Notkins, A. L., 1970, Neutralization of sensitized virus by purified components of complement, Proc. Nat. Acad. Sci. 65: 528.PubMedGoogle Scholar
  25. Davis, S. D., Janetta, A., Wedgewood, R. J., 1972, Bactericidal reactions in serum, in: Biological Activities of Complement ( D. G. Ingram, ed.), p. 43, Karger, Basel.Google Scholar
  26. Donaldson, V. H., Evans, R. R., 1963, A biochemical abnormality in hereditary angioneurotic edema: absence of serum inhibitor of CI esterase, Amer. J. Med. 35: 37.PubMedGoogle Scholar
  27. Donaldson, V. H., Merler, E., Rosen, F. S., Kretschmer, K. W., Lepow, I. H., 1970, A polypeptide kinin in hereditary angioneurotic edema plasma: role of complement in its formation, J. Lab. Clin. Med. 76: 986.Google Scholar
  28. Fischer, H., 1965, Lysophosphatide und Komplementlyse, Bull. Schweiz. Akad. Med. Wiss. 21: 471.Google Scholar
  29. Gigli, I., Austen, K. F., 1969, Fluid phase destruction of C2hu by C1hu. I. Its enhancement and inhibition by homologous and heterologous C4, J. Exp. Med. 129: 679.PubMedGoogle Scholar
  30. Gigli, I., Ruddy, S., Austen, K. F., 1968, The stoichiometric measurement of the serum inhibitor of the first component of complement by the inhibition of immune hemolysis, J. Immunol. 100: 1154.PubMedGoogle Scholar
  31. Gigli, I., Kaplan, A., Austen, K. F., 1971, Alteration in complement component utilization following the interaction of C1hu with kallikrein fragment, J. Immunol. 107: 311.Google Scholar
  32. Green, H., Barrow, P., Goldberg, B., 1959, Effect of antibody and complement on permeability control in ascites tumor cells and erythrocytes, J. Exp. Med. 110: 699.PubMedGoogle Scholar
  33. Henson, P. M., 1972, Complement dependent adherence of cells to antigen and antibody mechanism and consequences, in: Biologic Activities of Complement, Guelph, 1970 ( D. G. Ingram, ed.), pp. 173–210, Karger, Basel.Google Scholar
  34. Hoffman, E. M., 1969a, Inhibition of complement by a substance isolated from human erythrocytes. I. Extraction from human erythrocyte stromata, Immunochemistry 6: 391.PubMedGoogle Scholar
  35. Hoffman, E. M., 1969b, Inhibition of complement by a substance isolated from human erythrocytes. II. Studies on the site and mechanism of action, Immunochemistry 6: 405.Google Scholar
  36. Hoffmann, L. G., 1960, Purification of the first and fourth component of guinea pig complement and studies on their mechanisms and action, Thesis, School of Hygiene and Public Health, Johns Hopkins University, Baltimore.Google Scholar
  37. Humphrey, J. H., Dourmashkin, R. R., 1969, The lesions in cell membranes caused by complement, Adv. Immunol. 11: 75.PubMedGoogle Scholar
  38. Humphrey, J. H., Dourmashkin, R. R., Payne, S. N., 1968, The nature of lesions in cell membranes produced by action of complement and antibodies, The Fifth International Immunopathology Symposium (P. A. Miescher and P. Grabar, eds.), pp. 209–220, Schwabe, Basel.Google Scholar
  39. Iles, G. H., Seeman, P., Naylor, D., Cinader, ?., 1973, Membrane lesions in immune hemolysis. Surface rings, globule aggregates and transient openings, J. Cell Biol. 56: 528.Google Scholar
  40. Ishizaka, T., Ishizaka, K., Borsos, T., Rapp, H., 1966, CI fixation by human isoagglutinin: fixation of CI by γG and γM but not by γA antibody, J. Immunol. 97: 716.PubMedGoogle Scholar
  41. Ishizaka, T., Ishizaka, S., Salomon, S., Fudenberg, H., 1967, Biologic activities of aggregated γ- globulin: VIII. Aggregated immunoglobulins of different classes, J. Immunol. 99: 82.PubMedGoogle Scholar
  42. W.Ishizaka, K., Ishizaka, T., Lee, J. M., 1970, Biological function of the Fc-fragments of E-myeloma protein, Immunochemistry 7: 687.Google Scholar
  43. Kaplan, A. D., Vogt, W., 1974, Relation of complement with other plasma enzyme systems, in: Progress in Immunology II, Vol. I ( L. Brent and J. Holborow, eds.), p. 305, North Holland Publishing Copm., Amsterdam and Oxford.Google Scholar
  44. Kehoe, J. M., Fougereau, M., 1969, Immunoglobulin peptide with complement fixing activity, Nature 224: 1212.PubMedGoogle Scholar
  45. Klemperer, M. R., Rosen, F. S., Donaldson, V. H., 1969, A polypeptide derived from the second component of human complement (c2) which increases vascular permeability, J. Clin. Invest. 48: 44a.Google Scholar
  46. Koethe, S. M., Austen, K. F., Gigli, I., 1973, Blocking of the hemolytic expression of the classical complement sequence by products of complement activation via the alternate pathway. Materials responsible for the blocking phenomenon and their proposed mechanism of action, J. Immunol. 110: 390.PubMedGoogle Scholar
  47. Kolb, W. P., Müller-Eberhard, H. J., 1973, The membrane attack mechanism of complement. Verification of the stable C5–9 complex in free solution, J. Exp. Med. 138: 438.PubMedGoogle Scholar
  48. Lachmann, P. J., Müller-Eberhard, H. J., 1968, The demonstration in human serum of “conglutinogen activating factor” and its effect on the third component of complement, J. Immunol. 100: 691.PubMedGoogle Scholar
  49. Lachmann, P. J., Thompson, R. A., 1970, Reactive lysis: the complement-mediated lysis of unsensitized cells. II. The characterization of activated reactor as C5b and the participation of C8 and C9, J. Exp. Med. 131: 643.PubMedGoogle Scholar
  50. Leon, M. A., 1965, Complement: inactivation of second component by p-hydroxymercuribenzoate, Nature 147: 1034.Google Scholar
  51. Lepow, I. H., 1971, Biologically active fragments of complement, Prog. Immunol. 1: 579.Google Scholar
  52. Lepow, I. H., Ratnoff, O. J., Rosen, F. S., Pillemer, L., 1956a, Observation on a proesterase associated with partially purified first component of human complement, Proc. Soc. Exp. Biol. Med. 92: 32.PubMedGoogle Scholar
  53. Lepow, I. H., Ratnoff, O. J., Pillemer, L., 1956b, Elution of an esterase from antigen-antibody aggregates treated with human complement, Proc. Soc. Exp. Biol. Med. 92: 111.PubMedGoogle Scholar
  54. Lepow, J. H., Naff, G. B., Todd, E., Pensky, J., Hinz, Jr., C. F., 1963, Chromatographic resolution of the first component of human complement into three activities, J. Exp. Med. 117: 983.PubMedGoogle Scholar
  55. Levy, L., Lepow, I. H., 1959, Assay and properties of serum inhibitor of CI-esterase, Proc. Soc. Exp. Biol. Med. 101: 608.PubMedGoogle Scholar
  56. Loos, M., Wolf, H. U., Opferkuch, W., 1972, The C1-inactivation from guinea pig serum. III. Characterization and kinetic data of the reaction between the inactivator and EAC1 and EAC14, Immunochemistry 9: 451.PubMedGoogle Scholar
  57. Loos, M., Borsos, T., Rapp, H. J., 1973, The first component of complement in serum: evidence for a hitherto unrecognized factor in CI necessary for internal activation, J. Immunol. 110: 205.PubMedGoogle Scholar
  58. Manni, J., Müller-Eberhard, H. J., 1969, The eighth component of human complement (C8): isolation, characterization, and hemolytic efficiency, J. Exp. Med. 130: 1145.PubMedGoogle Scholar
  59. Mayer, M. M., 1960, Development of the One-Hit Theory of Immune Hemolysis, Immunochemical Approaches to Problems in Microbiology, Rutgers University Press, New Brunswick, New Jersey.Google Scholar
  60. Mayer, M. M., 1964, Complement and complement fixation, in: Experimental Immunochemistry ( Kabat, E. A. and Mayer, M. M., eds.), pp. 133–240, Charles Thomas, Springfield.Google Scholar
  61. Mayer, M. M., 1972, Mechanism of cytolysis by complement, Proc. Nat. Acad. Sci. 69: 2954.PubMedGoogle Scholar
  62. Mayer, M. M., 1973, The complement system: a foreign cell in the body is identified by antibody, but the cell is destroyed by other agents. Among them is “complement,” an intricately linked set of enzymes, Sci. Amer. 229: 54.PubMedGoogle Scholar
  63. Mayer, M. M., Levine, L., Rapp, H. J., Marucci, A. A., 1954, Kinetic studies on immune hemolysis. VII. Decay of EAC1, 4, 2 fixation of C3 and other factors influencing the hemolytic action of complement, J. Immunol. 73: 443.PubMedGoogle Scholar
  64. Mayer, M. M., Shin, S., Miller, J. A., 1967, Fragmentation of guinea pig complement components C2 and C3c, Prot. Biol. Fluids 15: 411.Google Scholar
  65. Miyakawa, Y., Sekine, T., Shimada, K., Nishioka, K., 1969, High efficiency of SAC 142 conversion to S* with EDTA-treated rat serum, J. Immunol. 103: 374.PubMedGoogle Scholar
  66. Molenaar, J. L., Mülller, M. A. R., Engelfriet, C. P., Pondman, K. W., 1974, Changes in antigenic properties of human C3 upon activation and conversion by trypsin, J. Immunol. 112: 1444.PubMedGoogle Scholar
  67. Muschel, L. H., 1965, Immune bactericidal and bacteriolytic reactions, in: Wolstenholme and Knight Complement, Ciba Foundation symposium, pp. 155–168, Little, Brown, and Co., Boston.Google Scholar
  68. Miiller, F., Feddersen, H., Segerling, M., 1973, Studies on the action of lysozyme in immune immobilization of Treponema pallidum (Nichols strain), Immunol. 24: 711.Google Scholar
  69. Müller-Eberhard, H. J., 1974, Serum complement system, in: Textbook of Immunopathology 2nd Ed., ( P. A. Miescher and H. J. Müller-Eberhard, eds.), p. 33, Gruner and Stratton, New York.Google Scholar
  70. Müller-Eberhard, H. J., Calcott, M. A., 1966, Interaction between Clq and gamma G-globulin, Immunochemistry 3: 500.Google Scholar
  71. Müller-Eberhard, H. J., Dalmasso, A. P., Calcott, M. A., 1966, The reaction mechanism of β1C- globulin in immune hemolysis, J. Exp. Med, 123: 33.Google Scholar
  72. Müller-Eberhard, H. J., Polley, M. J., Calcott, M. A., 1967, Formation and functional significance of a molecular complex derived from the second and the fourth component of human complement, J. Exp. Med. 125: 359.PubMedGoogle Scholar
  73. Naff, G. B., Ratnoff, O. D., 1968, The enzymatic nature of Clr. Conversion of Cls to CI esterase and digestion of amino acid esters by Clr, J. Exp. Med. 128: 571.PubMedGoogle Scholar
  74. Nelson, R. A., 1962, Immune adherence, in: IInd International Symposium on Immunopathology, Brook Lodge, Michigan, p. 245, Schwabe, Basel.Google Scholar
  75. Nelson, R. A., 1974, The complement system, in: The Inflammatory Process, 2nd Ed., Vol. 3, ( B. W. Zweifach, R. T. Mc. Cluskey, and H. L. Gernat, eds.) Academic Press, New York.Google Scholar
  76. Nilsson, U. R., Mapes, J., 1973, Polyacrylamide gel electrophoresis (PAGE) of reduced and dissociated C3 and C5: studies of the polypeptide chain (PPC) subunits and their modifications by trypsin (TRY) and C42–C423, J. Immunol. 111: 293.Google Scholar
  77. Nilsson, U. R., Mandle, R. J., Jr., McConnel-Mapes, J. A., 1975, Human C3 and C5: subunit structure and modifications by trypsin and C42 and C423, J. Immunol. 114: 815.PubMedGoogle Scholar
  78. Opferkuch, W., 1967, Physical and functional properties of guinea pig CI, Prot. Biol. Fluids 15: 459.Google Scholar
  79. Opferkuch, W., Loos, M., Borsos, T., 1971a, Isolation and characterization of a factor from human and guinea pig serum that accelerates the decay of SAC142, J. Immunol. 107: 313.Google Scholar
  80. Opferkuch, W., Rapp, H. J., Colten, H. R., Borsos, T., 1971b, Immune hemolysis and the functional properties of the second (C2) and the fourth (C4) components of complement. II. Clustering of effective C4,2 complexes at individual hemolytic sites, J. Immunol. 106: 407.PubMedGoogle Scholar
  81. Opferkuch, W., Rapp, H. J., Colten, H. R., Borsos, T., 1971c, The hemolytic properties of the fourth component of complement. III. The efficiency of human and guinea pig C4 and C2 estimated with rat C’EDTA, J. Immunol. 106: 927.PubMedGoogle Scholar
  82. Patrick, R. A., Taubman, S. ?., Lepow, I. H., 1970, Cleavage of the fourth component of human complement (C4) by activated Cls, Immunochemistry 7: 217.Google Scholar
  83. Pepys, M. ?., 1974, Role of complement in induction of antibody production in vivo. Effect of cobra factor and other C3-reactive agents on thymus dependent and thymus independent antibody response, J. Exp. Med. 140: 126.Google Scholar
  84. Perlmann, P., Holm, G., 1969, Cytotoxic effects of lymphoid cells in vitro, Adv. Immunol. 11: 117.PubMedGoogle Scholar
  85. Perlmann, P., Perlmann, H., Müller-Eberhard, H. J., Manni, H. A., 1969, Cytotoxic effects of leukocytes triggered by complement bound to target cells, Nature 163: 937.Google Scholar
  86. Pillemer, L., Seifter, J., San Clemente, C. L., Ecker, E. E., 1943, Immunochemical studies on human serum. III. The preparation and physico-chemical characterization of CI of human complement, J. Immunol. 47: 205.Google Scholar
  87. Pillemer, L., Blum, L., Lepow, I. H., Ross, O. A., Todd, E. W., Wardlaw, A. C., 1954, The properdin system and immunity. I. Demonstration and isolation of a new serum protein, properdin, and its role in immune phenomena, Nature 120: 279.Google Scholar
  88. Polley, M. J., Müller-Eberhard, H. J., 1966, Chemistry and mechanism of action of complement, Prog. Hematol. 5: 1.Google Scholar
  89. Polley, M. J., Müller-Eberhard, H. J., 1967, Enhancement of the hemolytic activity of the second component of human complement by oxidation, J. Exp. Med. 126: 1013.PubMedGoogle Scholar
  90. Polley, M. J., Müller-Eberhard, H. J., 1968, The second component of human complement: its isolation, fragmentation by CI-esterase and incorporation into C3 convertase, J. Exp. Med. 128: 533.PubMedGoogle Scholar
  91. Pondman, K. W., Rother, K. O., 1972, Biochemistry and biology of the third component of complement. European Complement Workshop, Amsterdam, 1972.Google Scholar
  92. Rapp, H. J., Borsos, T., 1970, Molecular Basis of Complement Action, Appleton-Century-Crofts, New York.Google Scholar
  93. Ratnoff, O. D., Pensky, J., Ogston, D., Naff, G. B., 1969, The inhibition of plasmin, plasma kallikrein, plasma permeability factor, and the Clr subcomponent of the first component of complement by serum CI esterase inhibitor, J. Exp. Med. 129: 315.PubMedGoogle Scholar
  94. Rother, K. (ed.), 1974, Komplement: Biochemie und Pathologie, Dr. D. Steinkopff-Verlag, Darmstadt.Google Scholar
  95. Rother, U., Hausch, G., Menzel, J., Rother, K., 1974, Deviated lysis: transfer of complement lytic activity to unsensitized cells. I. Generation of the transferable activity on the surface of complement resistant bacteria, Z. Immun. Forsch. 148: 172.Google Scholar
  96. Ruddy, S., Austen, K. F., 1971, C3b inactivator in man. II. Fragments produced by C3b inactivator cleavage of cell-bound or fluid phase C3b, J. Immunol. 107: 742.PubMedGoogle Scholar
  97. Sakai, K., Stroud, R. M., 1973, Purification, molecular properties, and activation of CI proesterase, Cls, J. Immunol. 110: 1010.Google Scholar
  98. Schreiber, R. D., Müller-Eberhard, H. J., 1974, Fourth component of human complement. Description of a three polypeptide chain structure, J. Exp. Med. 140: 1324.PubMedGoogle Scholar
  99. Segerling, M., Ohanian, S. H., Borsos, T., 1975, Chemotherapeutic drugs increase killing of tumor cells by antibody and complement, Nature 188: 55.Google Scholar
  100. Shelton, E., Yonemasu, K., Stroud, R. M., 1972, Ultrastructure of the human complement component, Clq, Proc. Nat. Acad. Sci. U.S.A. 69: 65.Google Scholar
  101. Shin, H. S., Mayer, M. M., 1968, The third component of guinea pig complement. II. Kinetic study of the reaction of EAC 42a with guinea pig C3. Enzymatic nature of C3 consumption, multiphasic character of fixation, and hemolytic titration of C3, Biochemistry 7: 2997.PubMedGoogle Scholar
  102. Shin, H. S., Snyderman, R., Friedman, E., Mellors, A., Mayer, M. M., 1968, Chemotactic and anaphylatoxic fragment cleaved from the fifth component of guinea pig complement, Nature 162: 361.Google Scholar
  103. Sitomer, G., Stroud, R. M., Mayer, M. M., 1966, Reversible adsorption of C2 by EAC4: role of Mg2+, enumeration of competent SAC4, two-step nature of C2a fixation and estimation of its efficiency, Immunochemistry 3: 57.PubMedGoogle Scholar
  104. Stolfi, R. L., 1968, Immune lytic transformation: a state of irreversible damage generated as a result of the reaction of the eighth component in the guinea pig complement system, J. Immunol. 100: 46.PubMedGoogle Scholar
  105. Stroud, R. M., Mayer, M. M., Miller, J. A., McKenzie, A. T., 1966, C2ad, an inactive derivative of C2 released during decay of EAC4, 2a, Immunochemistry 3: 163.PubMedGoogle Scholar
  106. Tamura, N., Nelson, R. A., 1967, Three naturally occurring inhibitors of components of complement in guinea pig and rabbit serum, J. Immunol. 99: 582.PubMedGoogle Scholar
  107. Valentine, R. C., Green, N. M., 1967, Electron microscopy of an antibody hapten complex, J. Mol. Biol. 27: 615.PubMedGoogle Scholar
  108. Valet, G., Cooper, N. R., 1974a, Isolation and characterization of the proenzyme form of Cls subunits of the first complement component, J. Immunol. 112: 339.PubMedGoogle Scholar
  109. Valet, G., Cooper, N. R., 1974b, Isolation and characterization of the proenzyme form of the Clr subunit of the first complement component, J. Immunol. 112: 1667.PubMedGoogle Scholar
  110. Valet, G., Opferkuch, W., 1975, Mechanism of complement induced cell lysis: demonstration of a three step mechanism of EAC 1–8 lysis by C9 and of a nonosmotic swelling of the erythrocytes, J. Immunol. 115: 1028.PubMedGoogle Scholar
  111. Vogt, W., 1974, Activation, activities and pharmacologically active products of complement, Pharm. Rev. 26: 125.Google Scholar
  112. Wellek, ?., Opferkuch, W., 1975, A case of deficiency of the seventh component of complement in man. Biological properties of a C7-deficient serum and description of an C7 inactivating principle, J. Clin. Exp. Immunol. 19:223.Google Scholar
  113. Wellek, B., Hahn, H. H., Opferkuch, W., 1975, Evidence for macrophage C3d-receptor active in phagocytosis, J. Immunol. 114: 1643.PubMedGoogle Scholar
  114. Zimmermann, T. S., Arroyave, C. M., Müller-Eberhard, H. J., 1971, A blood coagulation abnormality in rabbits, deficient in the sixth component of complement (C6) and its correction by purified C6, J. Exp. Med. 134: 1591.Google Scholar

Copyright information

© Plenum Publishing Corporation 1977

Authors and Affiliations

  • W. Opferkuch
    • 1
  • M. Segerling
    • 1
  1. 1.Institute for Medical MicrobiologyRuhr-University BochumBochumGermany

Personalised recommendations